| Product Code: ETC7635500 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market - Industry Life Cycle |
3.4 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market - Porter's Five Forces |
3.5 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about non-24-hour sleep-wake disorder |
4.2.2 Rising prevalence of non-24-hour sleep-wake disorder in Ireland |
4.2.3 Technological advancements in diagnosis and treatment of sleep disorders |
4.3 Market Restraints |
4.3.1 Stringent regulatory approvals for new drugs in Ireland |
4.3.2 Limited availability of specialized healthcare professionals for non-24-hour sleep-wake disorder |
4.3.3 High cost associated with treatment and medication for non-24-hour sleep-wake disorder |
5 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Trends |
6 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market, By Types |
6.1 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Circadian Rhythm Sleep Disorder, 2021- 2031F |
6.1.4 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Hypernychthemeral Syndrome, 2021- 2031F |
6.1.5 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Shift Work Disorder, 2021- 2031F |
6.1.6 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Jet Lag and Others, 2021- 2031F |
6.2 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Therapeutic Devices, 2021- 2031F |
6.2.3 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.4 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Nonbenzodiazepines, 2021- 2031F |
6.3.3 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.3.4 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Home Care Settings, 2021- 2031F |
6.5.4 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Wellness Centers and Spa, 2021- 2031F |
6.5.6 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.6.3 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.6.4 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6.5 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Import-Export Trade Statistics |
7.1 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Export to Major Countries |
7.2 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Imports from Major Countries |
8 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Key Performance Indicators |
8.1 Percentage increase in the number of diagnosed non-24-hour sleep-wake disorder cases in Ireland |
8.2 Patient adherence rate to prescribed treatment plans for non-24-hour sleep-wake disorder |
8.3 Number of clinical trials and research studies conducted on new drugs and treatment methods for non-24-hour sleep-wake disorder |
9 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market - Opportunity Assessment |
9.1 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market - Competitive Landscape |
10.1 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Revenue Share, By Companies, 2024 |
10.2 Ireland Non-24-Hour Sleep-Wake Disorder Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here